FindTrial
Sign In

Evaluation and comparison of different methodologies for the diagnosis of schistosomiasis.

Evaluation of new diagnostic methodologies for schistosomiasis mansoni in the current epidemiological scenario.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-59j8xf
Enrollment
Unknown
Registered
2018-09-27
Start date
2018-10-18
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schistosomiasis

Interventions

This is a cross-sectional study in individuals living in an area endemic for schistosomiasis with an estimated positivity of 28.1%, where different methodologies for diagnosing schistosomiasis in bio
Other

Sponsors

centro de Pesquisas René Rachou
Lead Sponsor
centro de Pesquisas René Rachou
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Residents of the Santa Rita Neighborhood; both genders; over 6 years and less than 105 years.

Exclusion criteria

Exclusion criteria: Have received treatment for Schistosoma mansoni infection in less than 12 months from the date of collection of the biological samples; do not deliver or allow collection of biological samples.

Design outcomes

Primary

MeasureTime frame
presence of Schistosoma mansoni eggs in faeces from participants identified by the Kato-Katz method.;CCA antigen detected in participant's urine samples by the POC_CCA method. ;DNA of the parasite detected in faeces and urine samples of the participant by the methods of LAMP, RPA, qPCR and PCR-ELISA.;Absorbance values greater than 10% of the mean absorbance of the negative control in ELISA assays using S. mansoni antigens—

Secondary

MeasureTime frame
Secondary outcomes are not expected—

Countries

Brazil

Contacts

Public ContactCristina Fonseca

centro de Pesquisas René Rachou

ctoscano@minas.fiocruz.br+55-031-33497828

Outcome results

None listed

Source: REBEC (via WHO ICTRP)